Cancer Immune Therapy Edited by G. Stuhler and P. Walden ...

148 7 Immunosuppresive Factors in Cancer
199 Shimizu, T., R. Abe, H. Nakamura,
A. Ohkawara, M. Suzuki and J. Nishihira.
1999. High expression of macrophage
migration inhibitory factor in human
melanoma cells and its role in tumor
cell growth and angiogenesis. Biochem.
Biophys. Res. Commun. 264: 751.
200 Ogawa, H., J. Nishihira,Y. Sato,
M. Kondo, N. Takahashi, T. Oshima
and S. Todo. 2000. An antibody for
macrophage migration inhibitory factor
suppresses tumour growth and inhibits
tumour-associated angiogenesis. Cytokine
12: 309.
201 Apte, R. S., D. Sinha, E. Mayhew,
G. J. Wistow and J. Y. Niederkorn.
1998. Cutting edge: Role of macrophage
migration inhibitory factor in inhibiting
NK cell activity and preserving
immune privilege. J. Immunol. 160:
5693.
202 Repp, A. C., E. S. Mayhew, S. Apte and
J. Y. Niederkorn. 2000. Human uveal
melanoma cells produce macrophage
migration-inhibitory factor to prevent
lysis by NK cells. J. Immunol. 165: 710.
203 Abe, R., T. Peng, J. Sailors, R. Bucala
and C. N. Metz. 2001. Regulation of
the CTL response by macrophage migration
inhibitory factor. J. Immunol.
166: 747.
204 thor Straten, P., P. Guldberg,
D. Schrama, M. A. Andersen,
U. Moerch, T. Seremet, C. Siedel,
R. A. Reisfeld and J. C. Becker. 2001.
In situ cytokine therapy: redistribution
of clonally expanded T cells. Eur. J. Immunol.
31: 250.
205 Shrikant, P. and M. F. Mescher.
1999. Control of syngeneic tumor
growth by activation of CD8 + T cells: efficacy
is limited by migration away
from the site and induction of nonresponsiveness.
J. Immunol. 162: 2858.
206 Hanson, H. L., D. L. Donermeyer,
H. Ikeda, J. M. White,V. Shankaran,
L. J. Old, H. Shiku, R. D. Schreiber
and P. M. Allen. 2000. Eradication of established
tumors by CD8 + Tcell adoptive
immunotherapy. Immunity. 13:265.
207 Shrikant, P. and M. F. Mescher.
1999. Control of syngeneic tumor
growth by activation of CD8 + T cells: efficacy
is limited by migration away
from the site and induction of nonresponsiveness.
J. Immunol. 162: 2858.
208 Smith,W. L., D. L. DeWitt and
R. M. Garavito. 2000. Cyclooxygenases:
structural, cellular and molecular
biology. Annu. Rev. Biochem. 69:
145.
209 Eberhart, C. E., R. J. Coffey, A. Radhika,
F. M. Giardiello, S. Ferrenbach
and R. N. Dubois. 1994. Up-regulation
of cyclooxygenase 2 gene expression
in human colorectal adenomas
and adenocarcinomas. Gastroenterology
107: 1183.
210 Dimberg, J., A. Samuelsson, A. Hugander
and P. Soderkvist. 1999. Differential
expression of cyclooxygenase 2
in human colorectal cancer. Gut 45:
730.
211 Soslow, R. A., A. J. Dannenberg,
D. Rush, B. M. Woerner, K. N. Khan,
J. Masferrer and A. T. Koki. 2000.
COX-2 is expressed in human pulmonary,
colonic and mammary tumors.
Cancer 89: 2637.
212 Schrey, M. P. and K. V. Patel. 1995.
Prostaglandin E2 production and metabolism
in human breast cancer cells
and breast fibroblasts. Regulation by inflammatory
mediators. Br. J. Cancer 72:
1412.
213 Lee, D. Y., J. R. Lupton and R. S. Chapkin.
1992. Prostaglandin profile and
synthetic capacity of the colon: comparison
of tissue sources and subcellular
fractions. Prostaglandins 43: 143.
214 Sitter, T., B. Haslinger, S. Mandl,
H. Fricke, E. Held and A. Sellmayer.
1998. High glucose increases prostaglandin
E 2 synthesis in human peritoneal
mesothelial cells: role of hyperosmolarity.
J. Am. Soc. Nephrol. 9: 2005.
215 Hsu, P., M. Shibata and C. W. Leffler.
1993. Prostanoid synthesis in response
to high CO2 in newborn pig brain microvascular
endothelial cells. Am. J.
Physiol. 264: H1485.
216 Williams, J. A. and E. Shacter. 1997.
Regulation of macrophage cytokine
production by prostaglandin E2. Distinct
roles of cyclooxygenase-1 and -2.
J. Biol. Chem. 272: 25693.
217 Renz, H., J. H. Gong, A. Schmidt,
M. Nain and D. Gemsa. 1988. Release